Correction to When Multi-Cancer Blood Screens Could Finally Take Off — Barrons.com
By Bill AlpertInvestors have waited with varying levels of patience for multi-cancer screening tests to lift off toward a targeted $30 billion to $50 billion in annual volume. Sales this year from the blood tests will be lucky to top $400 million.But things are looking up, as more tests find their…